| abstract |
Agents and methods for diagnosis of breast and ovarian cancer are disclosed. These agents are targets for immunological and anti-nucleic acid therapy to prevent and stop breast and ovarian cancer in humans. Such agents including ten genes (L-oncogenes) transcribed, in the opposite direction, from the locus of genes predisposing for breast cancer, the proteins encoded in these genes, the promoters that program transcription of the genes and endogenous antibodies produced in human blood, serum, saliva, urine, etc., against the proteins expressed by the ten L-oncogenes. |